Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

UNC Libraries(2025)10.17615/kfcn-nf74Source: DataRank Database

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials is a research paper published in UNC Libraries (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (17)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Afshin Mashadi-Hossein ORCID,Kathleen Tenner ORCID,Lisa A. Carey ORCID,Zhuo Li ORCID,Heather Ann Brauer ORCID

Live enrichment

PubMed:35610260

National Institutes of Health

Grant: 3U24CA196171-04S1

THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE

National Institutes of Health

Grant: 3U10CA180821-02S2

Alliance for Clinical Trials in Oncology Operations Center

National Institutes of Health

Grant: 5UG1CA233180-02

NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care

National Institutes of Health

Grant: 5U10CA180882-02

Statistics and Data Center for the Alliance for Clinical Trials in Oncology

National Institutes of Health

Grant: 3UG1CA232760-06S1

NCI, National Clinical Trials Network Lead Academic Participating Site (LAPS) UG1 (funded extension)

National Institutes of Health

Grant: 1UG1CA233373-01

UNC Lead Academic Participating Site

goldLicense: CC BY

https://doi.org/10.1038/s41523-022-00430-0

https://dx.doi.org/10.17615/kfcn-nf74

https://pubmed.ncbi.nlm.nih.gov/35610260

http://dx.doi.org/10.1038/s41523-022-00430-0

https://hdl.handle.net/11351/8055

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

Other subheadings::Other subheadings::Other subheadings::/drug therapyFENÓMENOS Y PROCESOS::fenómenos del sistema inmunitario::relación dosis-respuesta inmunológicaOtros calificadores::Otros calificadores::Otros calificadores::/farmacoterapiaNeoplasms. Tumors. Oncology. Including cancer and carcinogensPHENOMENA AND PROCESSES::Genetic Phenomena::Gene Expression Regulation::Gene Expression Regulation, NeoplasticSciences bio-médicales et agricolesExpressió gènicaArticleResposta immunitàriaFENÓMENOS Y PROCESOS::fenómenos genéticos::regulación de la expresión génica::regulación de la expresión génica neoplásicaMama - Càncer - TractamentPHENOMENA AND PROCESSES::Immune System Phenomena::Dose-Response Relationship, ImmunologicENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mamaRC254-282DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms

Sustainable Development Goals

SDG 3: 3. Good health